CXCL12 and neoplasm: As described in this section, SDF-1/CXCR4 signaling reportedly contributes to neoplastic transformation, malignant tumor progression, infiltration, metastasis, angiogenesis and vasculogenesis, and consequently therapy resistance of many different tumor entities.